ID26665A - Antagonis vla-4 - Google Patents

Antagonis vla-4

Info

Publication number
ID26665A
ID26665A IDW20001404A ID20001404A ID26665A ID 26665 A ID26665 A ID 26665A ID W20001404 A IDW20001404 A ID W20001404A ID 20001404 A ID20001404 A ID 20001404A ID 26665 A ID26665 A ID 26665A
Authority
ID
Indonesia
Prior art keywords
vla
antagonists
Prior art date
Application number
IDW20001404A
Other languages
English (en)
Indonesian (id)
Inventor
Sompong Wattanasin
Peter Joseph Von Matt
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ID26665A publication Critical patent/ID26665A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/42Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IDW20001404A 1998-01-23 1999-01-21 Antagonis vla-4 ID26665A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1233698A 1998-01-23 1998-01-23
US11072398P 1998-12-03 1998-12-03

Publications (1)

Publication Number Publication Date
ID26665A true ID26665A (id) 2001-01-25

Family

ID=26683440

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001404A ID26665A (id) 1998-01-23 1999-01-21 Antagonis vla-4

Country Status (13)

Country Link
EP (1) EP1049665A1 (no)
JP (1) JP4564654B2 (no)
KR (1) KR20010034317A (no)
CN (1) CN1294576A (no)
AU (1) AU746174B2 (no)
BR (1) BR9907733A (no)
CA (1) CA2318639A1 (no)
EE (1) EE200000428A (no)
HU (1) HUP0100336A3 (no)
ID (1) ID26665A (no)
IL (1) IL137329A0 (no)
NO (1) NO20003694L (no)
WO (1) WO1999037605A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60036918D1 (de) 1999-01-22 2007-12-13 Elan Pharm Inc Verbindungen die die vla-4 vermittelte adhäsion von leukozyten inhibieren
WO2000043372A1 (en) * 1999-01-22 2000-07-27 Elan Pharmaceuticals, Inc. Acyl derivatives which treat vla-4 related disorders
US6436904B1 (en) 1999-01-25 2002-08-20 Elan Pharmaceuticals, Inc. Compounds which inhibit leukocyte adhesion mediated by VLA-4
WO2000051974A1 (en) 1999-03-01 2000-09-08 Elan Pharmaceuticals, Inc. Alpha-aminoacetic acid derivatives useful as alpha 4 beta 7 - receptor antagonists
JP2003516380A (ja) * 1999-12-07 2003-05-13 ノバルティス アクチエンゲゼルシャフト Vla−4インテグリンアンタゴニスト
PL357109A1 (en) 1999-12-28 2004-07-12 Pfizer Products Inc. Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
DE10019755A1 (de) * 2000-04-20 2001-11-08 Bayer Ag Neue Aminoaryl/cycloalkylcarbonsäuren als Integrinantagonisten
GB2367816A (en) * 2000-10-09 2002-04-17 Bayer Ag Urea- and thiourea-containing derivatives of beta-amino acids
GB2369357A (en) * 2000-10-09 2002-05-29 Bayer Ag Aliphatic, cyclic amino carboxylic acids as integrin antagonists
GB2377933A (en) 2001-07-06 2003-01-29 Bayer Ag Succinic acid derivatives useful as integrin antagonists
TWI281470B (en) 2002-05-24 2007-05-21 Elan Pharm Inc Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
TW200307671A (en) 2002-05-24 2003-12-16 Elan Pharm Inc Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins
TW200610754A (en) * 2004-06-14 2006-04-01 Daiichi Seiyaku Co Vla-4 inhibitor
GB0523576D0 (en) * 2005-11-18 2005-12-28 Theradeas Ltd Drug composition and its use in therapy
WO2008103378A2 (en) 2007-02-20 2008-08-28 Merrimack Pharmaceuticals, Inc. Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist
PL2288715T3 (pl) 2008-04-11 2015-03-31 Merrimack Pharmaceuticals Inc Łączniki będące albuminą surowicy ludzkiej i ich koniugaty

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6306840B1 (en) * 1995-01-23 2001-10-23 Biogen, Inc. Cell adhesion inhibitors
IL136584A (en) * 1997-12-23 2005-03-20 Aventis Pharma Ltd SUBSTITUTED beta-ALANINES, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND USES THEREOF

Also Published As

Publication number Publication date
EE200000428A (et) 2001-12-17
NO20003694L (no) 2000-09-20
NO20003694D0 (no) 2000-07-19
EP1049665A1 (en) 2000-11-08
CN1294576A (zh) 2001-05-09
JP4564654B2 (ja) 2010-10-20
JP2002501039A (ja) 2002-01-15
IL137329A0 (en) 2001-07-24
WO1999037605A1 (en) 1999-07-29
HUP0100336A2 (hu) 2001-07-30
BR9907733A (pt) 2000-10-17
KR20010034317A (ko) 2001-04-25
CA2318639A1 (en) 1999-07-29
HUP0100336A3 (en) 2002-11-28
AU746174B2 (en) 2002-04-18
AU2829299A (en) 1999-08-09

Similar Documents

Publication Publication Date Title
DE69930183D1 (de) Anästhesiegerät
DE60000003T2 (de) Paroxetinmethansulfonat
NO990113D0 (no) Flerskrog-fart°y
ID23761A (id) Trisiklik tersubstitusi
NO992692D0 (no) Nefadozon doseringsform
NO994626D0 (no) Substituerte benzamider
EE200000171A (et) Uued NPY antagonistid
DE69908262D1 (de) Sprühbehälter
ID26665A (id) Antagonis vla-4
ID26223A (id) Antagonis reseptor vitronektin
ID29914A (id) Senyawa benzensulfonamida heterosiklik sebagai antagonis bradikinin
ID23219A (id) Trisiklik tersubstitusi
ID22838A (id) Oksazolidina sebagai antagonis 5-ht2a
ID27845A (id) Turunan tetrahidrokuilina sebagai antagonis glisilina
ID28811A (id) Antagonis reseptor vitronektin
NO990717D0 (no) Monitor-st°ttemekanisme
DE59907109D1 (de) Vliesleger
FR2782671B3 (fr) Livre
DE59907108D1 (de) Vliesleger
ID26508A (id) Oksim-oksim tersubstitusi sebagai antagonis-antagonis neurokinin
ATE303996T1 (de) Substituierte acylaminophenyl-uracile
DE59912188D1 (de) Substituierte phenyluracile
DE59911610D1 (de) Substituierte benzoylcyclohexandione
FI980856A0 (fi) Andningsskydd utrustad med en identifierare
DE59903934D1 (de) Sprühdose